Carter Ledyard assisted Trinity Biotech plc, a leader in the biotech industry specializing in point-of-care and clinical laboratory diagnostic testing, in a $115,000,000 private placement debt offering which priced on Thursday, April 2. The transaction closed on Thursday, April 9, 2015. Associates Mary Winchurch Brown and Matthew B. James and partners Alan J. Bernstein, James Gadsden, Steven J. Glusband, Yoram Keinan and Andris J. Vizbaras represented Trinity as its U.S. counsel.
Stay Connected